Biotechnology
New patent for the drug Amgen Inc. LUMAKRAS – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published in New patent for Amgen Inc.’s LUMACRAS drug
Annual Drug Patent Expiration for LUMAKRAS
Lumakras is a drug marketed by Amgen Inc and included in one NDA. It is available from a single supplier. There are three patents protecting this drug.
This drug has eighty-three patent family members in thirty-three countries.
The generic ingredient in LUMACRAS is sotorasiv. One registered supplier for this compound. Additional details are available on the sotorasib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for Amgen Inc.’s LUMACRAS drug
